Recursion Pharmaceuticals is trading at $3.76, up 6.96%, alongside a broad U.S. market rebound on November 9.
- U.S. stocks recovered from the prior week’s AI-related sell-off.
- No clear company-specific announcement explaining the intraday gain surfaced; the company’s latest reported earnings and clinical updates were announced November 2.
- Reliable live volume details are unavailable, so the trading activity level is unconfirmed.